Literature DB >> 151717

Effects of penicillamine and hydroxyquinoline on absorption of orally ingested 65zinc in the rat.

K Weismann, L Knudsen.   

Abstract

The influence of high doses of 2 chelating agents, D-penicillamine and iodochlorohydroxyquin, on the metabolism of orally ingested 65 Zn was studied on rats by means of whole body counting assay technique. Both drugs were found to increase zinc absorption in a dose-dependent way to values significantly above those of the untreated control group. At identical doses D-penicillamine had a significantly stronger enhancing effect than the 8-hydroxyquinoline derivate, except for the highest dosage which was 100 mg daily. The turnover of the absorbed 65Zn fraction was followed during the time of observation which was 11 days. The elimination rate was practically identical in all experimental groups, except for the 100 mg D-penicillamine group in which the biological half-life of 65Zn was significantly decreased as compared to the control group.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 151717     DOI: 10.1111/1523-1747.ep12515094

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.

Authors:  Stephanie Schäfer; Frank-Gerald Pajonk; Gerd Multhaup; Thomas A Bayer
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

2.  The effect of oral zinc loading on the absorption of 65zinc in the rat.

Authors:  H Høyer; K Weismann
Journal:  Arch Dermatol Res       Date:  1979-05-04       Impact factor: 3.017

3.  Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica.

Authors:  Jim Geiser; Robert C De Lisle; David Finkelstein; Paul A Adlard; Ashley I Bush; Glen K Andrews
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.